Impact of Serum Phosphate in Mechanically Ventilated Patients With Severe Sepsis and Septic Shock

Background: Hypo- and hyperphosphatemia are common in severe sepsis and septic shock. Published outcome data in patients with phosphate derangements primarily focus on hypophosphatemia and the general critically ill population. This study aimed to determine the impact of serum phosphate on clinical outcomes in patients with severe sepsis and septic shock. Methods: A retrospective cohort analysis of adult mechanically ventilated patients with severe sepsis or septic shock was performed. Patients were randomly selected from an internal intensive care unit (ICU) database at an academic medical center in the United States and screened for inclusion and exclusion criteria. Time-weighted phosphate was calculated using all phosphate measurements obtained during ICU admission. The associations between time-weighted phosphate and duration of mechanical ventilation, 28-day mortality, and ICU and hospital length of stay were evaluated using linear or logistic regression as appropriate. Results: One-hundred ninety-seven patients were evaluated: 33 were categorized as hypophosphatemia, 123 as normophosphatemia, and 41 as hyperphosphatemia. Patients with time-weighted hyperphosphatemia had a higher Simplified Acute Physiology Score III score and incidence of septic shock. Significantly higher rates of 28-day mortality were observed among those with time-weighted phosphate levels above 3.5 mg/dL. However, both time-weighted hypo- and hyperphosphatemia were associated with decreased duration of mechanical ventilation. For every 0.5 mg/dL increase in time-weighted phosphate referent values from 4.0 to 6.0, the duration of mechanical ventilation decreased by 8% to 26%. For every 0.5 mg/dL decrease in time-weighted phosphate referent values from 3.0 to 1.0, significant decreases in duration of mechanical ventilation ranged from 14% to 41%. Conclusion: Time-weighted hyperphosphatemia may be associated with increased mortality in mechanically ventilated patients with severe sepsis or septic shock. However, time-weighted hypo- and hyperphosphatemia were associated with decreased duration of mechanical ventilation. Future studies should further describe the impact of hypo- and hyperphosphatemia on clinical outcomes among critically ill patients with severe sepsis or septic shock.

[1]  Jiang‐hua Chen,et al.  Hypophosphatemia during continuous veno-venous hemofiltration is associated with mortality in critically ill patients with acute kidney injury , 2013, Critical Care.

[2]  J. Schold,et al.  Hypophosphatemia during continuous hemodialysis is associated with prolonged respiratory failure in patients with acute kidney injury. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[3]  D. Yeh,et al.  Association of Serum Phosphate Levels and Anemia in Critically Ill Surgical Patients , 2017, JPEN. Journal of parenteral and enteral nutrition.

[4]  K. Ultee,et al.  Elevated serum phosphate levels are associated with decreased amputation‐free survival after interventions for critical limb ischemia , 2017, Journal of vascular surgery.

[5]  R. D'Agostino,et al.  Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. , 2007, Archives of internal medicine.

[6]  M. Aubier,et al.  Effect of hypophosphatemia on diaphragmatic contractility in patients with acute respiratory failure. , 1985, The New England journal of medicine.

[7]  Dong Ki Kim,et al.  Electrolyte and mineral disturbances in septic acute kidney injury patients undergoing continuous renal replacement therapy , 2016, Medicine.

[8]  T. Evans,et al.  Glucose control and mortality in critically ill patients. , 2004, JAMA.

[9]  M. Wolzt,et al.  Hyperphosphatemia Is an Independent Risk Factor for Mortality in Critically Ill Patients: Results from a Cross-Sectional Study , 2015, PloS one.

[10]  A. Zlotnik,et al.  Association between Hypophosphatemia and Cardiac Arrhythmias in the Early Stage of Sepsis: Could Phosphorus Replacement Treatment Reduce the Incidence of Arrhythmias? , 2014, Electrolyte & blood pressure : E & BP.

[11]  M. Boaz,et al.  Severe hypophosphatemia in sepsis as a mortality predictor. , 2006, Annals of clinical and laboratory science.

[12]  M. Uematsu,et al.  Impact of deteriorated calcium-phosphate homeostasis on amputation-free survival after endovascular revascularization in patients with critical limb ischemia on hemodialysis , 2016, Vascular medicine.

[13]  J. Vincent,et al.  [Hypophosphatemia in critically ill patients]. , 2011, Revue medicale de Bruxelles.

[14]  P. Bacchetti,et al.  Sample size calculations in clinical research. , 2002, Anesthesiology.

[15]  V. Debari,et al.  Association of hypophosphatemia with failure-to-wean from mechanical ventilation. , 2010, Annals of clinical and laboratory science.

[16]  S. Papa,et al.  Reactive oxygen species, mitochondria, apoptosis and aging , 2004, Molecular and Cellular Biochemistry.

[17]  H. Schiffl,et al.  Severe acute hypophosphatemia during renal replacement therapy adversely affects outcome of critically ill patients with acute kidney injury , 2013, International Urology and Nephrology.

[18]  Y. Shoenfeld,et al.  Association between hypophosphatemia and cardiac arrhythmias in the early stages of sepsis. , 2002, European journal of internal medicine.

[19]  B. Giraudeau,et al.  Heterogeneity in the definition of mechanical ventilation duration and ventilator-free days. , 2014, American journal of respiratory and critical care medicine.

[20]  S. Moe,et al.  Direct effects of phosphate on vascular cell function. , 2011, Advances in chronic kidney disease.

[21]  P. Royston,et al.  Regression using fractional polynomials of continuous covariates: parsimonious parametric modelling. , 1994 .

[22]  R. Bellomo,et al.  The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). , 2016, JAMA.